Month: July 2020

EHDEN now working with 28 Data Partners across 11 countries to harmonise clinical data across therapeutic areas including COVID-19

by

28 July 2020, Brussels, Belgium. Healthcare today is ever more complex, with growing expectations from our advancing insights into our own biology, diseases, their diagnosis, treatment and outcomes, and innovation in those treatments. Working within individual institutions to generate insights in the 21st century is much more challenging, hence collaboration, and at scale across multiple … Read more

EHDEN project collaborating with the European Medicines Agency and partners to address COVID-19 in Europe

by

22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data & Evidence Network (EHDEN) is delighted to announce its involvement in establishing a European framework and research network for the conduct of multicentre cohort studies on the use of medicines in COVID-19 patients. The European Medicines Agency (EMA) has announced a … Read more

Meet the EHDEN partners – David van Brunt

by

David van Brunt Senior Research Fellow and Head, Division of Evidence and Analytics AbbVie Introduce yourself and AbbVie? AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s Mission is to use its expertise, dedicated people and a … Read more